Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.8.0.1
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Statements of Operations [Abstract]        
Revenue
Operating expenses:        
Research and development, net of reimbursements 4,957,464 5,685,777 13,840,862 13,599,174
General and administrative 1,726,527 1,394,910 7,816,762 6,363,825
Depreciation expense 11,048 20,078 46,303 57,670
Total operating expenses 6,695,039 7,100,765 21,703,927 20,020,669
Loss from operations (6,695,039) (7,100,765) (21,703,927) (20,020,669)
Other income (expense):        
Interest income (expense) 49 (666) 49 (5,007)
Gain on change in fair value of derivative liabilities 372,117 502,778 265,714 2,399,639
Total other income (expense) 372,166 502,112 265,763 2,394,632
Net loss $ (6,322,873) $ (6,598,653) $ (21,438,164) $ (17,626,037)
Net loss per common share - basic and diluted $ (0.09) $ (0.14) $ (0.34) $ (0.38)
Weighted average common shares outstanding - basic and diluted 72,543,003 47,651,906 62,267,794 46,126,928